Effects of antipsychotics on bone mineral density and prolactin levels in patients with schizophrenia: a 12-month prospective study

Effects of antipsychotics on bone mineral density and prolactin levels in patients with schizophrenia: a 12-month prospective study

Objective: Effects of conventional and atypical antipsychotics on bone mineral density (BMD) and serum prolactin levels (PRL) were examined in patients with schizophrenia. Methods: One hundred and sixty-three first-episode inpatients with schizophrenia were recruited, to whom one of three conventio...

Full description

Bibliographic Details
Main Authors:	Wang, Mengxin (Author), Hou, Ruihua (Author), Jian, Jia (Author), Mi, Guolin (Author), Qiu, Huimin (Author), Cao, Bingyu (Author), Tang, Maoqin (Author)
Format:	Article
Language:	English
Published:	2014-03-03.
Subjects:	Article
Online Access:	Get fulltext

Similar Items

EFFECT OF TYPICAL AND ATYPICAL ANTIPSYCHOTICS ON PLASMA PROLACTIN LEVELS IN SCHIZOPHRENIA
by: Muhammad Sami Bilal, et al.
Published: (2015-01-01)

Serum prolactin levels and sexual dysfunction in patients with schizophrenia treated with antipsychotics: comparison between aripiprazole and other atypical antipsychotics
by: Eiji Kirino
Published: (2017-11-01)

Prolactin response to antipsychotics: An inpatient study.
by: Liana Dehelean, et al.
Published: (2020-01-01)

Efficacy and acceptability of three prolactin-sparing antipsychotics in patient with schizophrenia: a network meta-analysis
by: Jianjie Huang, et al.
Published: (2019-10-01)

Change in Prolactin Levels in Pediatric Patients Given Antipsychotics for Schizophrenia and Schizophrenia Spectrum Disorders: A Network Meta-Analysis
by: Chakrapani Balijepalli, et al.
Published: (2018-01-01)

The Effects of Antipsychotics on Prolactin Levels and Women’s Menstruation
by: S. I. Bargiota, et al.
Published: (2013-01-01)

Usefulness and limitation of DDD and PDD analyses. 12 months of solid oral antipsychotics prescribing data for the NHS-reimbursed treatment of schizophrenia in Italy
by: Lorenzo Pradelli
Published: (2008-01-01)

Switching antipsychotics: Results of 16-month non-interventional, prospective, observational clinical research of inpatients with schizophrenia spectrum disorders
by: Bole Cvetka Bačar, et al.
Published: (2017-03-01)

Antipsychotic monotherapy and polypharmacy in the naturalistic treatment of schizophrenia with atypical antipsychotics
by: Correll Christoph, et al.
Published: (2005-05-01)

New atypical antipsychotics for schizophrenia: iloperidone
by: Silvio Caccia, et al.
Published: (2010-02-01)

ADHERENCE TO ANTIPSYCHOTIC MEDICATION IN SCHIZOPHRENIA PATIENTS
by: Peter Pregelj
Published: (2009-01-01)

Cost of antipsychotic polypharmacy in the treatment of schizophrenia
by: Correll Christoph U, et al.
Published: (2008-04-01)

Antipsychotic agents: efficacy and safety in schizophrenia
by: de Ara&uacute;jo AN, et al.
Published: (2012-11-01)

Osteoporosis Associated with Antipsychotic Treatment in Schizophrenia
by: Haishan Wu, et al.
Published: (2013-01-01)

Antipsychotics Persistence of Patients with Schizophrenia in Taiwan
by: Chia-ChengLai, et al.
Published: (2010)

Adherence of the discharged schizophrenias to the antipsychotic medications
by: ZENG,WEN-QI, et al.
Published: (1990)

Utilization of Antipsychotic Agents in Patients with Schizophrenia
by: Chia-Wei Hung, et al.

Adult Patients with Schizophrenia and Noncompliance with Antipsychotics
by: Arceo, Jan Michael, et al.
Published: (2018)

Antipsychotic drugs and sexual function in schizophrenia
by: Mahmoud, Ahmed Mohamed
Published: (2008)

Prolactin and Psychopathology in Schizophrenia: A Literature Review and Reappraisal
by: Ravi Philip Rajkumar
Published: (2014-01-01)

Unresolved Issues for Utilization of Atypical Antipsychotics in Schizophrenia: Antipsychotic Polypharmacy and Metabolic Syndrome
by: Sang Won Jeon, et al.
Published: (2017-10-01)

Synaptic density marker SV2A is reduced in schizophrenia patients and unaffected by antipsychotics in rats
by: Ellis Chika Onwordi, et al.
Published: (2020-01-01)

Inpatient resource use and costs associated with switching from oral antipsychotics to aripiprazole once-monthly for the treatment of schizophrenia
by: Michele Wilson, et al.
Published: (2016-03-01)

The effect of antipsychotic medication on sexual function and serum prolactin levels in community-treated schizophrenic patients: results from the Schizophrenia Trial of Aripiprazole (STAR) study (NCT00237913)
by: Pans Miranda, et al.
Published: (2008-12-01)

The Correlation Between the Changes in Prolactin and Psychotic Symptoms in Patients with Schizophrenia
by: Yu-Hui Huang, et al.
Published: (2015)

Thalamic shape abnormalities in antipsychotic naïve schizophrenia
by: Vijay Danivas, et al.
Published: (2013-01-01)

Entorhinal cortex volume in antipsychotic-naïve schizophrenia
by: Sam P Jose, et al.
Published: (2012-01-01)

Pharmacoeconomic assessment of antipsychotic treatment in outpatients with schizophrenia
by: I. A. Vilyum, et al.
Published: (2018-05-01)

The therapeutic relationship and adherence to antipsychotic medication in schizophrenia.
by: Rosemarie McCabe, et al.
Published: (2012-01-01)

Antipsychotics and risk of natural death in patients with schizophrenia
by: Chen Y, et al.
Published: (2019-07-01)

Predictors of switching antipsychotic medications in the treatment of schizophrenia
by: Stauffer Virginia L, et al.
Published: (2010-09-01)

THE ROLE OF ATYPICAL ANTIPSYCHOTIC DECREASING AGGRESIVENESS IN SCHIZOPHRENIA
by: Juvita Novia Anggraini Maria
Published: (2013-03-01)

Atypical antipsychotics in the treatment of early-onset schizophrenia
by: Hrdlicka M, et al.
Published: (2015-04-01)

Oculomotor and neuropsychological effects of antipsychotic treatment for schizophrenia
by: Kristian S. Hill, et al.
Published: (2009-04-01)

Regional brain metabolism in schizophrenia: The influence of antipsychotics
by: Seethalakshmi R, et al.
Published: (2007-01-01)

The Study of Antipsychotic-induced Osteoporosis in Inpatients with Schizophrenia
by: Ping-Wing Lui, et al.
Published: (2009)

The effects of antipsychotic drugs on depression level in patients with schizophrenia: clozapine vs. other atypical antipsychotics
by: Burkay Yakar, et al.
Published: (2016-08-01)

Factors associated with decreased bone mineral density in postmenopausal women with schizophrenia
by: Liang Y, et al.
Published: (2016-02-01)

A 12-Month Retrospective Analysis of Three Long-Acting Antipsychotic Injections in Patients with Schizophrenia: Comparison of Medication Adherence with Psychiatric Hospitalization Rates, Cost of Services, and Concomitant Medications
by: Chuc, Alan, et al.
Published: (2007)

Comparison of Plasma Neurosteroid and Prolactin Levels in Patients with Schizophrenia and Healthy Individuals
by: Forough Riahi, et al.
Published: (2016-01-01)

Cannot write session to /tmp/vufind_sessions/sess_206hu9c0lsalk4an2bcs1ur3d3